# US Oncology Information Systems Market

> US Oncology Information Systems Market Research Report: Size, Share, Trend Analysis By End-User (Hospitals & Oncology Clinics, Government Institutes, Research Centers) By Applications (Medical Oncology, Radiation Oncology, Surgical Oncology) By Product and Service Type (Software, Professional Services) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.65%
- **2024:** $ 1,803.2 Million
- **2025:** $ 1,941.14 Million
- **2035:** $ 4,057.76 Million
- **Key Players:** Varian Medical Systems (US), Elekta AB (SE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions (US)

**Report ID:** MRFR/HC/16516-CR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** January 29, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-oncology-information-systems-market-18044

---

## Market Summary

## US Oncology Information Systems Market Highlighted Trends & Dynamics

The US Oncology Information Systems (OIS) market is experiencing a surge in demand, driven by the rising complexity of cancer care and the need for integrated solutions to manage patient data efficiently. Oncology Information Systems play a pivotal role in streamlining oncology workflows, from diagnosis to treatment planning and ongoing patient management.

**Increasing Cancer Incidence:** The growing incidence of cancer in the United States has heightened the demand for advanced information systems in oncology. These systems help healthcare providers manage the vast amount of data associated with cancer patients, ensuring comprehensive and coordinated care.

**Comprehensive Patient Data Management:** OIS enables healthcare professionals to consolidate and manage patient information seamlessly. This includes electronic health records (EHR), imaging data, pathology reports, and treatment plans, providing a comprehensive view of each patient's medical history and facilitating collaborative decision-making among oncology teams.

**Integration of Treatment Planning:** Oncology Information Systems integrate treatment planning tools, allowing oncologists to design and optimize personalized treatment regimens. This integration improves the efficiency of treatment delivery and ensures that patients receive the most effective therapies tailored to their specific cancer type and stage.

**Efficiency and Workflow Optimization:** The demand for OIS is driven by the need for efficiency in oncology practices. These systems automate routine tasks, reduce paperwork, and streamline administrative processes, allowing healthcare providers to focus more on patient care and less on administrative burdens.

**Advancements in Radiation Oncology:** The field of radiation oncology has witnessed significant advancements, and OIS plays a crucial role in supporting these developments. The integration of OIS with radiation therapy planning systems enhances precision in treatment delivery, minimizing side effects and improving overall treatment outcomes.

**Interoperability and Data Exchange:** OIS contributes to the interoperability of healthcare systems by facilitating seamless data exchange between different departments and institutions. This interoperability is essential for collaborative cancer care, enabling oncologists to access relevant patient information regardless of the healthcare facility.

**Telemedicine and Remote Patient Monitoring:** The COVID-19 pandemic has accelerated the adoption of telemedicine in oncology, and OIS plays a vital role in supporting remote patient monitoring and virtual consultations. This capability has become essential for ensuring continuity of care while minimizing patient exposure to potential health risks.

**Precision Medicine and Genomic Data Integration:** With the rise of precision medicine, OIS incorporates genomic data into the decision-making process. This integration allows oncologists to tailor treatments based on the genetic profile of individual patients, leading to more targeted and effective therapeutic strategies.

**Regulatory Compliance and Security:** The demand for OIS is influenced by the need for regulatory compliance and data security in healthcare. As patient data becomes increasingly digital, ensuring compliance with regulations such as HIPAA and implementing robust security measures are critical factors shaping the market.

## Market Drivers

### Rising Cancer Incidence Rates

The oncology information-systems market is experiencing growth due to the increasing incidence of cancer in the US. According to the American Cancer Society, approximately 1.9 million new cancer cases are expected to be diagnosed in 2025. This rising trend necessitates advanced information systems to manage patient data, treatment plans, and outcomes effectively. As healthcare providers seek to enhance their capabilities in cancer care, the demand for sophisticated oncology information systems is likely to rise. These systems facilitate better data management, improve patient outcomes, and streamline workflows, thereby becoming essential tools in oncology practices. The growing patient population requiring oncology services is a significant driver for the expansion of the oncology information-systems market.

### Growing Demand for Patient-Centric Care

The oncology information-systems market is increasingly driven by the demand for patient-centric care. Patients are becoming more involved in their treatment decisions, leading to a need for systems that provide comprehensive information about their conditions and treatment options. Oncology information systems that facilitate patient engagement, education, and communication are gaining traction. This shift towards patient empowerment is prompting healthcare providers to adopt systems that enhance the patient experience. As a result, the market is likely to see a rise in solutions that prioritize patient needs, ultimately improving satisfaction and outcomes in oncology care.

### Technological Advancements in Healthcare

Technological innovations are transforming the oncology information-systems market. The integration of advanced technologies such as cloud computing, big data analytics, and machine learning is enhancing the capabilities of oncology information systems. These technologies enable healthcare providers to analyze vast amounts of patient data, leading to more personalized treatment plans and improved patient care. The market is projected to grow as these technologies become more accessible and affordable. For instance, the adoption of cloud-based solutions is expected to increase by 30% in the next few years, allowing for better data sharing and collaboration among healthcare professionals. This trend indicates a shift towards more efficient and effective oncology information systems.

### Regulatory Support and Funding Initiatives

Government initiatives and regulatory support play a crucial role in the oncology information-systems market. The US government has been actively promoting the use of health information technology through various funding programs and incentives. For example, the Health Information Technology for Economic and Clinical Health (HITECH) Act has provided substantial financial support to healthcare organizations for adopting electronic health records and related systems. This regulatory environment encourages the development and implementation of oncology information systems, as providers seek to comply with standards and improve care delivery. The infusion of funds into healthcare IT is likely to bolster the oncology information-systems market, making it a vital area for investment.

### Increased Focus on Data Security and Privacy

Data security and privacy concerns are becoming paramount in the oncology information-systems market. With the rise of cyber threats and data breaches, healthcare organizations are prioritizing the protection of sensitive patient information. Regulatory frameworks such as the Health Insurance Portability and Accountability Act (HIPAA) mandate strict compliance regarding patient data handling. Consequently, oncology information systems that incorporate robust security features are in high demand. The market is expected to grow as providers seek solutions that not only enhance operational efficiency but also ensure the confidentiality and integrity of patient data. This focus on security is likely to shape the future landscape of the oncology information-systems market.

## Future Outlook

The [Oncology Information Systems Market](https://www.marketresearchfuture.com/reports/oncology-information-systems-market-7080) is projected to grow at a 7.65% CAGR from 2025 to 2035, driven by technological advancements, increasing cancer prevalence, and demand for integrated solutions.

**New opportunities:**

- Development of AI-driven predictive analytics tools for treatment optimization. Expansion of telehealth platforms for remote oncology consultations. Integration of blockchain technology for secure patient data management.

By 2035, the oncology information-systems market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product and Service Type: Software (Largest) vs. Professional Services (Fastest-Growing)

In the US oncology information-systems market, the distribution of market share between Product and Service Types highlights Software as the largest segment, capturing a significant portion of the total share. Software solutions provide critical functionalities in patient management, data analysis, and treatment planning, making them indispensable for oncology practices. Meanwhile, Professional Services, though smaller in total share, represent a dynamic area of growth as healthcare facilities increasingly seek specialized support to optimize their oncology programs and enhance operational efficiency. The growth trends within this segment indicate a robust demand for both Software and Professional Services. The increasing complexity of cancer treatment requires sophisticated software solutions, while the rising emphasis on personalized care drives the need for professional consulting and training services. As innovations in technology continue to emerge, both segments are poised for significant development, with Professional Services emerging as the fastest-growing category due to its essential role in implementation and optimization of oncology systems.

Software (Dominant) vs. Professional Services (Emerging)

Software in the US [oncology information-systems market](../../../reports/oncology-information-systems-market-7080) holds a dominant position due to its critical role in streamlining patient information management and treatment protocols. Advanced software systems enhance data accuracy and improve decision-making in clinical settings, thus directly impacting patient outcomes. On the other hand, Professional Services are emerging as an essential complement to these technologies, providing necessary expertise for successful software implementation and ongoing system management. This segment encompasses consulting, training, and support services that facilitate the adaptation of oncology practices to new technologies and methodologies, making it a crucial aspect of the overall market ecosystem as healthcare providers strive for better patient care and operational excellence.

### By Application: Medical Oncology (Largest) vs. Radiation Oncology (Fastest-Growing)

The US oncology information-systems market is predominantly led by the Medical Oncology segment, which captures a significant share of the overall market, reflecting the high demand for comprehensive cancer treatment options, clinical workflows, and patient management systems. Radiation Oncology follows as a promising segment, increasingly gaining traction due to advancements in radiation therapy technology and its growing acceptance in treatment protocols. Growth within the oncology information-systems market is driven by technological innovations and an increasing emphasis on personalized medicine. With rising cancer incidence rates and a need for integrated treatment solutions, medical oncology remains the dominant segment. Meanwhile, radiation oncology is noted for its rapid expansion, fueled by the introduction of cutting-edge tools that enhance treatment accuracy and patient outcomes, positioning it as a vital component in cancer care.

Medical Oncology (Dominant) vs. Surgical Oncology (Emerging)

Medical oncology, as the dominant segment, focuses on chemotherapy, immunotherapy, and targeted therapies, utilizing sophisticated information systems for patient management and data analytics. It benefits from extensive adoption due to its foundational role in cancer care and treatment personalization. Surgical oncology, labeled as an emerging segment, specializes in surgical interventions for cancer treatment, integrating surgical planning software and patient tracking systems to enhance surgical outcomes. This segment is gaining attention as advances in minimally invasive techniques and robotic surgeries improve recovery times and effectiveness, thereby increasing its share in the ecosystem. Both segments emphasize the need for integrated systems that streamline patient care and optimize treatment pathways.

### By End-User: Hospitals & Oncology Clinics (Largest) vs. Research Centers (Fastest-Growing)

In the US oncology information-systems market, the distribution of market share among the end-user segments illustrates a clear dominance of hospitals and oncology clinics. This segment represents a significant portion of the market due to the high patient volume and advanced treatment protocols available in these institutions. Government institutes also hold a notable share but are not growing as rapidly as the fastest-growing segment. Research centers are emerging as influential players, carving out an essential niche in the market by focusing on innovative treatments and technologies. The growth trends in this market segment are driven by the increasing emphasis on personalized medicine and the integration of advanced data analytics in oncology practices. Hospitals and oncology clinics are adopting sophisticated information systems to enhance patient care and optimize operation efficiencies. Meanwhile, research centers are experiencing rapid expansion as they continuously seek funding for clinical trials and new therapies, thereby pushing boundaries in cancer care. This combination of established dominance along with emerging players positions the US oncology information-systems market for robust future growth.

Hospitals & Oncology Clinics (Dominant) vs. Research Centers (Emerging)

Hospitals and oncology clinics are the dominant end-users in the US oncology information-systems market, benefiting from their extensive patient base and comprehensive treatment facilities. These institutions utilize oncology information systems to streamline patient management, enhance clinical decision support, and improve overall treatment outcomes. On the other hand, research centers represent the emerging segment, characterized by their focus on pioneering cancer research and innovative treatment methodologies. They often operate in a highly specialized environment, enabling them to adapt quickly to new scientific advancements. As they leverage the latest technologies and secure funding for groundbreaking studies, research centers are increasingly asserting their influence in the oncology information systems landscape, complementing the established practices in hospitals and clinics.

## Competitive Benchmarking

The oncology information-systems market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing cancer prevalence, and a growing emphasis on personalized medicine. Major players such as Varian Medical Systems (US), Elekta AB (SE), and GE Healthcare (US) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Varian Medical Systems (US) focuses on integrating artificial intelligence (AI) into treatment planning, while Elekta AB (SE) emphasizes its commitment to precision radiation therapy. GE Healthcare (US) is actively pursuing digital transformation initiatives, which collectively shape a competitive environment that prioritizes technological integration and patient-centric solutions. Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for diverse offerings and fosters innovation, as companies strive to differentiate themselves through unique value propositions and advanced technologies. In October 2025, Varian Medical Systems (US) announced a partnership with a leading AI firm to develop advanced analytics tools aimed at improving treatment outcomes for oncology patients. This strategic move underscores Varian's commitment to harnessing AI capabilities, potentially enhancing its product offerings and solidifying its position as a leader in the oncology information-systems market. The integration of AI into treatment protocols may lead to more personalized care, aligning with current trends in precision medicine. In September 2025, Elekta AB (SE) launched a new software platform designed to streamline workflow in radiation therapy departments. This initiative reflects Elekta's focus on enhancing operational efficiency and improving patient care. By simplifying processes and reducing administrative burdens, Elekta aims to empower healthcare providers to deliver more effective treatments, thereby reinforcing its competitive edge in the market. In August 2025, GE Healthcare (US) unveiled a comprehensive digital health strategy that includes the development of cloud-based solutions for oncology data management. This strategic direction indicates GE's intent to capitalize on the growing demand for digital health solutions, positioning itself as a key player in the evolving landscape of oncology information systems. The emphasis on cloud technology may facilitate better data sharing and collaboration among healthcare providers, ultimately improving patient outcomes. As of November 2025, current competitive trends in the oncology information-systems market are heavily influenced by digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability. This shift may redefine how companies position themselves in the market, emphasizing the importance of advanced solutions and sustainable practices.

## Report Scope

| MARKET SIZE 2024 | 1803.2(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 1941.14(USD Million) |
| MARKET SIZE 2035 | 4057.76(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.65% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Varian Medical Systems (US), Elekta AB (SE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions (US) |
| Segments Covered | Product and Service Type, Application, End-User |
| Key Market Opportunities | Integration of artificial intelligence for enhanced patient data management in oncology information-systems market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in oncology information-systems, enhancing patient care and operational efficiency. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US oncology information-systems market in 2024?**
A: The market valuation was $1803.2 Million in 2024.

**Q: What is the projected market valuation for the US oncology information-systems market by 2035?**
A: The projected valuation for 2035 is $4057.76 Million.

**Q: What is the expected CAGR for the US oncology information-systems market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period is 7.65%.

**Q: Which companies are considered key players in the US oncology information-systems market?**
A: Key players include Varian Medical Systems, Elekta AB, Philips Healthcare, Siemens Healthineers, GE Healthcare, Cerner Corporation, McKesson Corporation, and Allscripts Healthcare Solutions.

**Q: What were the software and professional services market values in 2024?**
A: In 2024, the software market value was $1081.44 Million, while professional services were valued at $721.76 Million.

**Q: What are the projected values for medical, radiation, and surgical oncology by 2035?**
A: By 2035, medical oncology is projected to reach $1640.0 Million, radiation oncology $1210.0 Million, and surgical oncology $1207.76 Million.

**Q: What is the expected market value for hospitals and oncology clinics in 2035?**
A: The expected market value for hospitals and oncology clinics by 2035 is $2434.88 Million.

**Q: How do government institutes and research centers compare in market valuation for 2035?**
A: By 2035, government institutes are projected to reach $810.88 Million, while research centers are expected to reach $811.0 Million.

**Q: What segment of the US oncology information-systems market shows the highest growth potential?**
A: The software segment appears to show the highest growth potential, with a projected increase from $1081.44 Million in 2024.

**Q: What trends are influencing the growth of the US oncology information-systems market?**
A: Trends influencing growth include advancements in technology, increasing cancer prevalence, and the need for integrated healthcare solutions.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-oncology-information-systems-market-18044*